Science Researcher Update: Spotlight on Meetings, Conferences, and Events

The interactions between the mother and the fetus during the progression of normal pregnancy involve trade-offs, or even conflicts, between factors that improve maternal health and those that support fetal development and growth. These may lead to selective evolutionary pressures that differ among species, and result in intriguing differences in reproductive strategies that enhance maternal-fetal biological harmony, and mitigate conflict. Intriguing strategies to balance these pressures include imprinting, coincident with placentation. Adverse pregnancy outcomes, such as miscarriage, preterm birth, preeclampsia and intrauterine growth restriction, are heterogeneous, and gaps remain in understanding how imbalances between maternal and fetal adaptations contribute to these disorders. The goal of this meeting is to bring together investigators from diverse disciplines who investigate maternal and fetal factors that shape pregnancy outcomes by exploring how these systems work together or are at odds. The conference will aim to develop these concepts, illuminating developmental, genomic/epigenomic, immune, microbial and metabolic factors as well as consider how acute exposures during pregnancy, such as infection, shape maternal-fetal outcomes. Understanding the biology underpinning these considerations will contribute to better diagnosis, treatment and disease prevention during pregnancy. The presentations will address critical gaps in our knowledge of maternal/fetal harmony and conflict, and target paths to improve understanding of issues related to social, economic and geographic inequality that predispose some groups to enhanced risk during pregnancy. A better understanding of the biology, and development of new collaborative possibilities and paths to improved clinical outcomes, are primary goals of the meeting.

Synthetic biology is a movement to make biology easier to engineer, a passionate cabal of scientists, engineers, entrepreneurs, and investors on a mission to turn biology into a tech discipline. The market is predicted to be worth US$13.4 Billion by 2019. Come meet the pioneers who are applying engineered biology to revolutionize the production of chemicals, consumer products, energy, materials, medicine and more. Learn how their efforts are transforming manufacturing with a positive effect on conservation and the environment.

Now in our 6th year, we’ll be back at the gorgeous Mission Bay Conference Center in San Francisco on October 3rd and 4th. A networking event will take place on October 5th. With more than 14 sessions, 60 speakers and 25 exhibitors, come meet the movers and shakers of an industry that’s driving technology and business forward.

Key themes at the event this year include: biomaterials, biosecurity and policy, conservation and the environment, consumer products, education and public outreach. Learn about emerging applications for DNA, health and drug discovery, reproducibility, investment opportunities, and more. Come be inspired by what the future holds.

Join more than 800 attendees for the largest event focused exclusively on digital marketing for the life sciences — Digital Pharma East — now in it's eleventh year. Get actionable insights from our faculty of more than 120 senior-level experts when the conference returns to Philadelphia this October 3-6 at the Pennsylvania Convention Center.

There have been substantial alterations in the way that the digital health landscape has transitioned within the last year. These changes also bring some exciting potential solutions on the horizon, but there are still many questions being asked and we’re looking to explore some of those in 2017:

How will digital disruption transform the pharma business model?

How can pharma generate value from digital medicine solutions?

How can pharma engage with disruptive technologies?

How can we demonstrate the value of digital for pharma products?

How will pharma adapt to successfully engage HCPs?

We will explore these questions and more. Reserve your seat for the 11th Digital Pharma East conference to join the conversation and contribute to the advancement of digital health to improve patient outcomes customer centricity!

Since 2003, the Prevent Cancer Foundation® has convened a series of annual workshops focused on high-resolution CT imaging data for lung cancer, COPD and cardiovascular disease. The workshop provides a forum to exchange ideas on quantitative CT imaging for early disease management, as well as on policy and advocacy for responsible lung cancer, COPD and cardiovascular screening. The workshop emphasizes quality and consistency in screening.

As our Flagship event, The Festival of Genomics Boston provides a unique opportunity to meet with the whole of the genomics community, in an environment carefully constructed to facilitated networking, learning and business growth. 

Features:

Horizon Stages 1 & 2 
Broaden your view with our series of 20 minute keynotes from those doing the most essential work in the field. Sessions have been curated around 4 themes; Personalizing Medicine, Enabling Data, Precision Therapeutics and Research & Development.

Prism Stage
See the light as we break the big themes down in these panel style sessions.  Complex issues are channelled through the multiple perspectives and experiences of our panellists to help you illuminate the path forward.

In the Loop
Dive into the conversation with leaders in the field and fellow festival goers. This new forum leverages the undeniable wisdom of the Festival crowd to help you join the dots on critical issues. Places are limited for these, check back for more information.

Live Lounge
Pull up a beanbag and tune into bite sized insights from patients and clinicians, product demonstrations by leading solution providers, rare disease film screenings & a genomics play.

LCA XVII is the key conference in North America for Environmental Life Cycle Assessment (LCA) knowledge sharing and networking. With practical learning and insights from over 60 speakers, attendees from across industry, academia, government and NGO’s, and the very best in networking: LCA XVII is simply the best opportunity to learn about the state of the art and meet fellow practitioners.

Clinical pharmacy is a branch of pharmacy which deals with the patient care and medication and promotes health, wellness and disease inhibition. The pharmacist works in management with the doctors for the patient healthcare. Clinical pharmacists have wide education in the biomedical, pharmaceutical, and clinical sciences. Clinical Pharmacy consist of all the services accomplished by pharmacists practicing in hospitals, community pharmacies, nursing homes, home-based care services, clinics and any other setting wherever medicines are prescribed and used. The term "clinical" does not necessarily suggest an action implemented in a hospital setting. It defines that the type of activity is connected to the health of the patients. This suggests that community pharmacists and hospital pharmacists both can accomplish clinical pharmacy activities.

The conference is gearing up for an exciting and informative program which include Keynote, plenary lectures, symposia, workshops on a variety of topics, poster presentations and various training programs for participants from all over the world covering all the latest aspects of Clinical Pharmacy.

This gathering on Immunization will convey a chance to share potential advantages and constraints of antibodies in avoiding and control of infectious diseases and non-infectious diseases consequently improving the quality and longevity of life. Explore the ideas on Nanotechnology and Advances in Vaccine Technology. This session also discourses about the Pediatric Vaccination, vaccines in veterinary, plants and for pregnancy, Cancer Vaccines, Bacterial and Viral Vaccines. 

The Cells, Sensors, and Systems Symposium is a one day event, open to all, featuring cutting edge talks in extracellular vesicle biology and measurement by leaders in the field.

This will be the seventeenth biennial Neurobiology of Drosophila meeting, which will be held at Cold Spring Harbor Laboratory. The meeting will begin at 7:30 pm on Tuesday, October 3, and will conclude after lunch on Saturday, October 7. This year’s meeting will continue the bi-annual tradition of providing a forum for presentation of the most exciting and cutting-edge research currently ongoing in the field of neuroscience using the Drosophila model. With sessions ranging from synaptic transmission and neuronal development all the way to higher brain function and disease modeling, the program will provide broad coverage of the field from molecular to systems neuroscience. In addition, sessions focusing on technological innovations will supplement the program, allowing for dissemination of new methods that are revolutionizing neuroscience research. 

The connection between cancer and genome integrity is widely appreciated. Importantly, the greater New York Metropolitan area is unparalleled in the concentration of world leading research on chromosome biology and function, as well as for research at the interface between chromosome integrity and the dynamics of malignancy. The Genome Integrity Discussion Group capitalize on this concentration of excellence, providing a forum for interaction between basic- and clinically-oriented research groups working in these fields. These meetings not only facilitate synergy between labs, but also provide a context in which previously unappreciated complementarities can be revealed.

In that spirit, the talks will cover a broad range of areas, including, but not limited to the DNA damage response and cancer predisposition, DNA replication, transcription, chromatin modification, recombination, cell cycle control, telomeres, chromosome segregation, epigenetic states, as well as the emergence of new technologies relevant to research in genome integrity. Although a primary focus is upon basic mechanisms and processes, these areas are pertinent to cancer and myriad human disease states, and it is expected that this will be reflected in the substance of our discussions. At each of the meetings, two early career scientists (students or postdocs) are selected to present data.